1. Sorenson CM. Bcl-2 family members and disease. Biochim Biophys Acta 2004;1644:169-177.

2. Shore GC, Nguyen M. Bcl-2 proteins and apoptosis: Choose your partner. Cell 2008;135:1004-1006.

3. Lomonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: An overview. Oncogene 2008;27:S2–S19.

4. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol 2014;15:49-63.

5. Mukherjee N, Sheetz J, Shellman YG. Targeting the bcl2 family: Advances and challenges in bh3 mimetic-based therapies. Int J Mol Sci 2025;26:26.

6. Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 2016;1863:2977-2992.

7. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J. 2009 Jun;23(6):1625-37.

8. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell 2009;138:838-854.

9. Peng JJ, Song WT, Yao F, Zhang X, Peng J, Luo XJ, et al. Involvement of regulated necrosis in blinding diseases: Focus on necroptosis and ferroptosis. Exp Eye Res 2020;191:107922.

10. Wei S, Li J, Zhang Y, Li Y, Wang Y. Ferroptosis in eye diseases: A systematic review. Eye (Lond) 2025;39:18-27.

11. Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol 2024;25:424-442.

12. Kist M, Vucic D. Cell death pathways: Intricate connections and disease implications. EMBO J 2021;40:e106700.

13. Weinlich R, Oberst A, Beere HM, Green DR. Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol 2017;18:127-136.

14. Place DE, Lee S, Kanneganti TD. PANoptosis in microbial infection. Curr Opin Microbiol 2021;59:42-49.

15. Gullett JM, Tweedell RE, Kanneganti TD. It’s all in the pan: Crosstalk, plasticity, redundancies, switches, and interconnectedness encompassed by panoptosis underlying the totality of cell death-associated biological effects. Cells 2022;11:11.

16. Sun X, Yang Y, Meng X, Li J, Liu X, Liu H. PANoptosis: Mechanisms, biology, and role in disease. Immunol Rev 2024;321:246-262.

17. Pihán P, Carreras-Sureda A, Hetz C. BCL-2 family: Integrating stress responses at the ER to control cell demise. Cell Death Differ 2017;24:1478-1487.

18. Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 2018;25:486-541.

19. Green DR. The coming decade of cell death research: Five riddles. Cell 2019;177:1094-1107.

20. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 2010;11:700-714.

21. Khan N, Lawlor KE, Murphy JM, Vince JE. More to life than death: Molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling. Curr Opin Immunol 2014;26:76-89.

22. Shan B, Pan H, Najafov A, Yuan J. Necroptosis in development and diseases. Genes Dev 2018;32:327-340.

23. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC, et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 2010;88:1569-1576.

24. Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol 2024;25:379-395.

25. Newton K. RIPK1 and RIPK3: Critical regulators of inflammation and cell death. Trends Cell Biol 2015;25:347-353.

26. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, et al. Catalytic activity of the caspase- 8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011;471:363-367.

27. Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D, et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 2014;343:1357-1360.

28. Yu Z, Efstathiou NE, Correa VS, Chen X, Ishihara K, Iesato Y, et al. Receptor interacting protein 3 kinase, not 1 kinase, through MLKL-mediated necroptosis is involved in UVAinduced corneal endothelium cell death. Cell Death Discov 2021;7:366.

29. Samson AL, Zhang Y, Geoghegan ND, Gavin XJ, Davies KA, Mlodzianoski MJ, et al. MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis. Nat Commun 2020;11:3151.

30. Song YS, Wang S, Park S, Hanna B, Johnson KJ, Darjatmoko SR, et al. Receptor-interacting protein kinase- 3 expression impacts ocular vascular development and pathological neovascularization. Cells 2024;13:13.

31. Liu M, Li H, Yang R, Ji D, Xia X. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamateinduced retinal excitotoxic model of glaucoma. J Neuroinflammation 2022;19:262.

32. Feng Y, Hu C, Cui K, Fan M, Xiang W, Ye D, et al. Gsk840 alleviates retinal neuronal injury by inhibiting ripk3/mlklmediated rgc necroptosis after ischemia/reperfusion. Invest Ophthalmol Vis Sci 2023;64:42.

33. Cao L, Mu W. Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications. Pharmacol Res 2021;163:105297.

34. Chen Z, Gu X, Chen H, Zhang H, Liu J, Yang X, et al. Ripk1 senses s-adenosylmethionine scarcity to drive cell death and inflammation. Cell Metab 2025;37:1732-1749.E9.

35. Liu R, Wang G, Jiang Z, Zou T, Wang C, Wang W, et al. Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1. J Exp Med 2026;223:223.

36. Wang L, Yan H, Chen X, Lee J, Sun J, Liu G, et al. Caspase- 8 is involved in pyroptosis, necroptosis and the maturation and release of IL-1β in Aspergillus fumigatus keratitis. Int Immunopharmacol 2022;113 Pt A:109275.

37. Zhao T, Guo X, Sun Y. Iron accumulation and lipid peroxidation in the aging retina: Implication of ferroptosis in age-related macular degeneration. Aging Dis 2021;12:529-551.

38. Totsuka K, Ueta T, Uchida T, Roggia MF, Nakagawa S, Vavvas DG, et al. Oxidative stress induces ferroptotic cell death in retinal pigment epithelial cells. Exp Eye Res 2019;181:316-324.

39. Neiteler A, Palakkan AA, Gallagher KM, Ross JA. Oxidative stress and docosahexaenoic acid injury lead to increased necroptosis and ferroptosis in retinal pigment epithelium. Sci Rep 2023;13:21143.

40. Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol 2023;33:1077-1087.

41. Ufer C, Wang CC. The roles of glutathione peroxidases during embryo development. Front Mol Neurosci 2011;4:12.

42. Sun Y, Zheng Y, Wang C, Liu Y. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis 2018;9:753.

43. Jiang X, Stockwell BR, Conrad M. Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021;22:266-282.

44. Qin Y, Qiao Y, Wang D, Tang C, Yan G. Ferritinophagy and ferroptosis in cardiovascular disease: Mechanisms and potential applications. Biomed Pharmacother 2021;141:111872.

45. Dvoriantchikova G, Lypka KR, Adis EV, Ivanov D. Multiple types of programmed necrosis such as necroptosis, pyroptosis, oxytosis/ferroptosis, and parthanatos contribute simultaneously to retinal damage after ischemia-reperfusion. Sci Rep 2022;12:17152.

46. Zhang Y, Swanda RV, Nie L, Liu X, Wang C, Lee H, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun 2021;12:1589.

47. Dvoriantchikova G, Adis E, Lypka K, Ivanov D. Various forms of programmed cell death are concurrently activated in the population of retinal ganglion cells after ischemia and reperfusion. Int J Mol Sci 2023;24:24.

48. Hisatomi T, Nakao S, Murakami Y, Noda K, Nakazawa T, Notomi S, et al. The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization. Am J Pathol 2012;181:53-61.

49. Allocca M, Corrigan JJ, Mazumder A, Fake KR, Samson LD. Inflammation, necrosis, and the kinase RIP3 are key mediators of AAG-dependent alkylation-induced retinal degeneration. Sci Signal 2019;12:12.

50. Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN, Wong WT. Age-related alterations in the dynamic behavior of microglia. Aging Cell 2011;10:263-276.

51. Pandian N, Kanneganti TD. Panoptosis: A unique innate immune inflammatory cell death modality. J Immunol 2022;209:1625-1633.

52. Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 2022;375:1254-1261.

53. Lutsenko S, Roy S, Tsvetkov P. Mammalian copper homeostasis: Physiological roles and molecular mechanisms. Physiol Rev 2025;105:441-491.

54. Hossain MS, Das A, Rafiq AM, Deák F, Bagi Z, Outlaw R, et al. Altered copper transport in oxidative stress-dependent brain endothelial barrier dysfunction associated with Alzheimer’s disease. Vascul Pharmacol 2024;157:107433.

55. Das A, Ash D, Fouda AY, Sudhahar V, Kim YM, Hou Y, et al. Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis. Nat Cell Biol 2022;24:35-50.

56. Zimnicka AM, Tang H, Guo Q, Kuhr FK, Oh MJ, Wan J, et al. Upregulated copper transporters in hypoxia-induced pulmonary hypertension. PLoS One 2014;9:e90544.

57. Elner SG, Elner VM, Yoshida A, Dick RD, Brewer GJ. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization. Invest Ophthalmol Vis Sci 2005;46:299-303.

58. Tang D, Kang R. Transcriptional regulation of cuproptosis resistance in cancer therapy. Trends Cancer 2025;11:713-715.

59. Kim BE, Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol 2008;4:176-185.

60. Fukai T, Ushio-Fukai M, Kaplan JH. Copper transporters and copper chaperones: Roles in cardiovascular physiology and disease. Am J Physiol Cell Physiol 2018;315:C186–C201.

61. Gomathy Narayanan I, Saravanan R, Bharathselvi M, Biswas J, Sulochana KN. Localization of human copper transporter 1 in the eye and its role in eales disease. Ocul Immunol Inflamm 2016;24:678-683.

62. Yamamoto M, Ash D, Sudhahar V, Zaidi SA, Rojas MA, Xu Z, et al. Novel role of copper transporter ctr1 and therapeutic potential of copper chelators in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2025;66:70.

63. Xiong C, Ling H, Hao Q, Zhou X. Cuproptosis: p53- regulated metabolic cell death? Cell Death Differ 2023;30:876-884.

64. Song J, Ren K, Zhang D, Lv X, Sun L, Deng Y, et al. A novel signature combing cuproptosis- and ferroptosisrelated genes in sepsis-induced cardiomyopathy. Front Genet 2023;14:1170737.

65. Zhao WJ, Fan CL, Hu XM, Ban XX, Wan H, He Y, et al. Regulated cell death of retinal ganglion cells in glaucoma: Molecular insights and therapeutic potentials. Cell Mol Neurobiol 2023;43:3161-3178.

66. Zhang Q, Hu XM, Zhao WJ, Ban XX, Li Y, Huang YX, et al. Targeting necroptosis: A novel therapeutic option for retinal degenerative diseases. Int J Biol Sci 2023;19:658-674.

67. Yang Y, Sun X. Retinal ganglion cell death in glaucoma: Advances and caveats. Curr Eye Res 2023;48:1-10.

68. Shi G, Sato K, Takahashi N, Ohno-Ohishi M, Murayama N, Yamaguchi C, et al. AAV2-driven endothelin induces chronic reduced retinal blood flow/retinal ganglion cell loss in rats. Life Sci Alliance 2025;8:8.

69. Zhang D, Hu F, Li T, Liu H, Li Q, Cheng Y, et al. Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity. Exp Eye Res 2025;255:110352.

70. Li F, Zhang Q, Rong Y, Xiang S, Wang J. TAT-N24 enhances retinal ganglion cell survival by suppressing ZBP1-PANoptosome-mediated PANoptosis in an acute glaucoma mouse model. Exp Eye Res 2025;251:110244.

71. Kim BK, Goncharov T, Archaimbault SA, Roudnicky F, Webster JD, Westenskow PD, et al. RIP1 inhibition protects retinal ganglion cells in glaucoma models of ocular injury. Cell Death Differ 2025;32:353-368.

72. Feng L, Dai S, Zhang C, Zhang W, Zhu W, Wang C, et al. Ripa-56 protects retinal ganglion cells in glutamateinduced retinal excitotoxic model of glaucoma. Sci Rep 2024;14:3834.

73. Rong R, Zhou X, Liang G, Li H, You M, Liang Z, et al. Targeting cell membranes, depleting ros by dithiane and thioketal-containing polymers with pendant cholesterols delivering necrostatin-1 for glaucoma treatment. ACS Nano 2022;16:21225-21239.

74. Oh SE, Kim JH, Park CK, Park HL. Effect of bromfenac on reducing neuroinflammation in an ischemia-reperfusion glaucoma model. Cells 2024;13:13.

75. Qin Q, Yu N, Gu Y, Ke W, Zhang Q, Liu X, et al. Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury. Cell Death Dis 2022;13:507.

76. Do YJ, Sul JW, Jang KH, Kang NS, Kim YH, Kim YG, et al. A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model. Exp Cell Res 2017;359:30-38.

77. Wan H, Ban X, He Y, Yang Y, Hu X, Shang L, et al. Voltagedependent anion channel 1 oligomerization regulates PANoptosis in retinal ischemia-reperfusion injury. Neural Regen Res 2026;21:1652-1664.

78. Yao Y, Xu Y, Liang JJ, Zhuang X, Ng TK. Longitudinal and simultaneous profiling of 11 modes of cell death in mouse retina post-optic nerve injury. Exp Eye Res 2022;222:109159.

79. Tao Y, Murakami Y, Vavvas DG, Sonoda KH. Necroptosis and neuroinflammation in retinal degeneration. Front Neurosci 2022;16:911430.

80. Thomas CN, Thompson AM, Ahmed Z, Blanch RJ. Retinal ganglion cells die by necroptotic mechanisms in a sitespecific manner in a rat blunt ocular injury model. Cells 2019;8:8.

81. Huang Z, Zhou T, Sun X, Zheng Y, Cheng B, Li M, et al. Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation. Cell Death Differ 2018;25:180-189.

82. Olivares-González L, Velasco S, Campillo I, Rodrigo R. Retinal inflammation, cell death and inherited retinal dystrophies. Int J Mol Sci 2021;22:22.

83. Zhang PW, Wan ZH, Li W, Vats A, Mehta K, Fan L, et al. Ibuprofen reduces inflammation, necroptosis and protects photoreceptors from light-induced retinal degeneration. J Neuroinflammation 2025;22:20.

84. Lee M, Leskova W, Eshaq RS, Amezquita Z, Harris NR. Mechanisms of retinal photoreceptor loss in spontaneously hypertensive rats. Exp Eye Res 2024;247:110065.

85. Lei XL, Yang QL, Wei YZ, Qiu X, Zeng HY, Yan AM, et al. Identification of a novel ferroptosis-related gene signature associated with retinal degeneration induced by light damage in mice. Heliyon 2023;9:e23002.

86. Viringipurampeer IA, Metcalfe AL, Bashar AE, Sivak O, Yanai A, Mohammadi Z, et al. NLRP3 inflammasome activation drives bystander cone photoreceptor cell death in a P23H rhodopsin model of retinal degeneration. Hum Mol Genet 2016;25:1501-1516.

87. Gibbons L, Doyle S. A role for sarm1 in photoreceptor cell death. Adv Exp Med Biol 2025;1468:183-187.

88. Lu C, Li S, Jin M. Rapamycin inhibits light-induced necrosome activation occurring in wild-type, but not rpe65-null, mouse retina. Invest Ophthalmol Vis Sci 2022;63:19.

89. Yang F, Ma H, Butler MR, Ding XQ. Deficiency of type 2 iodothyronine deiodinase reduces necroptosis activity and oxidative stress responses in retinas of leber congenital amaurosis model mice. FASEB J 2018;32:fj201800484RR.

90. Ko KW, Milbrandt J, DiAntonio A. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration. J Cell Biol 2020;219:219.

91. Olivares-González L, Velasco S, Millán JM, Rodrigo R. Intravitreal administration of adalimumab delays retinal degeneration in rd10 mice. FASEB J 2020;34:13839-13861.

92. Yu Z, Correa VS, Efstathiou NE, Albertos-Arranz H, Chen X, Ishihara K, et al. UVA induces retinal photoreceptor cell death via receptor interacting protein 3 kinase mediated necroptosis. Cell Death Discov 2022;8:489.

93. He Y, Xu Y, Chen Z, He B, Quan Z, Zhang R, et al. Protective effect of mitochondrially targeted peptide against oxidant injury of cone photoreceptors through preventing necroptosis pathway. J Biomed Nanotechnol 2021;17:279-290.

94. Jang KH, Do YJ, Koo TS, Choi JS, Song EJ, Hwang Y, et al. Protective effect of RIPK1-inhibitory compound in in vivo models for retinal degenerative disease. Exp Eye Res 2019;180:8-17.

95. Dong K, Zhu H, Song Z, Gong Y, Wang F, Wang W, et al. Necrostatin-1 protects photoreceptors from cell death and improves functional outcome after experimental retinal detachment. Am J Pathol 2012;181:1634-1641.

96. Upadhyay M, Bonilha VL. Regulated cell death pathways in the sodium iodate model: Insights and implications for AMD. Exp Eye Res 2024;238:109728.

97. Xu J, Mo J, Liu X, Marshall B, Atherton SS, Dong Z, et al. Depletion of the receptor-interacting protein kinase 3 (rip3) decreases photoreceptor cell death during the early stages of ocular murine cytomegalovirus infection. Invest Ophthalmol Vis Sci 2018;59:2445-2458.

98. Wassmer SJ, Leonard BC, Coupland SG, Baker AN, Hamilton J, Hauswirth WW, et al. Overexpression of the x-linked inhibitor of apoptosis protects against retinal degeneration in a feline model of retinal detachment. Hum Gene Ther 2017;28:482-492.

99. Kim HI, Paik SS, Kim GH, Kim M, Kim SH, Kim IB. Neuroprotective effect of NecroX-5 against retinal degeneration in rodents. Neuroreport 2016;27:1128-1133.

100. Li J, Bao X, Guo S, Huang Y, Huang C, Hu J, et al. Cell death pathways in dry eye disease: Insights into ocular surface inflammation. Ocul Surf 2024;34:535-544.

111. Ma H, Yang F, Ding XQ. Inhibition of thyroid hormone signaling protects retinal pigment epithelium and photoreceptors from cell death in a mouse model of age-related macular degeneration. Cell Death Dis 2020;11:24.

112. Ma H, Yang F, Ding XQ. Deficiency of thyroid hormone receptor protects retinal pigment epithelium and photoreceptors from cell death in a mouse model of age-related macular degeneration. Cell Death Dis 2022;13:255.

113. Zhang A, Wei TT, Yin H, Tan CY, Han C, Yao Y, et al. Endoplasmic reticulum-mitochondria coupling prompts ZBP1-mediated RPE cell PANoptosis in age-related macular degeneration. Commun Biol 2025;8:1118.

114. Agrón E, Mares J, Clemons TE, Swaroop A, Chew EY, Keenan TD; AREDS and AREDS2 Research Groups. Dietary nutrient intake and progression to late age-related macular degeneration in the age-related eye disease studies 1 and 2. Ophthalmology 2021;128:425-442.

115. Tapiero H, Townsend DM, Tew KD. Trace elements in human physiology and pathology. Copper. Biomed Pharmacother 2003;57:386-398.

116. Yang Z, Su W, Wei X, Pan Y, Xing M, Niu L, et al. Hypoxia inducible factor-1α drives cancer resistance to cuproptosis. Cancer Cell 2025;43:937-954.e9.

117. Aloysius Dhivya M, Aberami S, Nikhalashree S, Biswas J, Liu W, Irudayaraj J, et al. Copper mediates mitochondrial biogenesis in retinal pigment epithelial cells. Biochim Biophys Acta Mol Basis Dis 2020;1866:165843.

118. Erie JC, Good JA, Butz JA, Pulido JS. Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration. Am J Ophthalmol 2009;147:276-282.e1.

119. Oshitari T. Neurovascular cell death and therapeutic strategies for diabetic retinopathy. Int J Mol Sci 2023;24:24.

120. Huang Z, Liang J, Chen S, Ng TK, Brelén ME, Liu Q, et al. RIP3-mediated microglial necroptosis promotes neuroinflammation and neurodegeneration in the early stages of diabetic retinopathy. Cell Death Dis 2023;14:227.

121. Gao S, Huang X, Zhang Y, Bao L, Wang X, Zhang M. Investigation on the expression regulation of RIPK1/RIPK3 in the retinal ganglion cells (RGCs) cultured in high glucose. Bioengineered 2021;12:3947-3956.

122. Gao N, Me R, Yu FX. Diabetes exacerbates pseudomonas aeruginosa keratitis in streptozotocin-induced and db/db mice via altering programmed cell death pathways. Invest Ophthalmol Vis Sci 2023;64:14.123. Hong Y, Wang Y, Cui Y, Pan J, Mao S, Zhu Y, et al. Microrna-124-3p attenuated retinal neovascularization in oxygen-induced retinopathy mice by inhibiting the dysfunction of retinal neuroglial cells through stat3 pathway. Int J Mol Sci 2023;24:24.

124. Liang A, Feng T, Gao X, Zhao B, Chen S. Identification of pdgfa as a neutrophil-related biomarker linked to the advancement of diabetic retinopathy through integrated bioinformatics analysis. Endocr Metab Immune Disord Drug Targets 2025;25:109-121.

125. Ni B, Yang Z, Zhou T, Zhou H, Zhou Y, Lin S, et al. Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway. J Neuroinflammation 2024;21:164.

126. He C, Liu Y, Huang Z, Yang Z, Zhou T, Liu S, et al. A specific RIP3+ subpopulation of microglia promotes retinopathy through a hypoxia-triggered necroptotic mechanism. Proc Natl Acad Sci USA 2021;118:118.

127. Xu X, Lan X, Fu S, Zhang Q, Gui F, Jin Q, et al. Dickkopf- 1 exerts protective effects by inhibiting PANoptosis and retinal neovascularization in diabetic retinopathy. Biochem Biophys Res Commun 2022;617:69-76.

128. Han G, Hu K, Luo T, Wang W, Zhang D, Ouyang L, et al. Research progress of non-coding RNA regulating the role of PANoptosis in diabetes mellitus and its complications. Apoptosis 2025;30:516-536.

129. Dascalu AM, Anghelache A, Stana D, Costea AC, Nicolae VA, Tanasescu D, et al. Serum levels of copper and zinc in diabetic retinopathy: Potential new therapeutic targets (Review). Exp Ther Med 2022;23:324.

130. Yang J, Gao Y, Mao H, Kuang X, Tian F. Qiju Dihuang Pill protects the lens epithelial cells via alleviating cuproptosis in diabetic cataract. J Ethnopharmacol 2024;333:118444.

131. Jiang Y, Qu W, Kong Q, Lu X. Panoptosis of retinal ganglion cells. J Integr Neurosci 2025;24:38216.